Literature DB >> 33466220

Arthritis associated with Mycoplasma pneumoniae in a pediatric patient: A case report.

Cristina Oana Mărginean1, Anca Meda Georgescu2, Lorena Elena Meliţ1.   

Abstract

INTRODUCTION: Mycoplasma pneumoniae (MP) infection in infants is usually overlooked and it might result in important complications if left untreated. MP-induced arthritis is probably the least common extrapulmonary manifestation and frequently leads to delays in the diagnosis. PATIENT CONCERNS: We report the case of a 2-year-old female child admitted in our clinic for prolonged fever (onset 2 weeks before the admission), for which the general practitioner established the diagnosis of acute pharyngitis and recommended antibiotics. But the fever persisted and the patient was referred to a pediatrician. DIAGNOSIS: The laboratory tests revealed leukocytosis with neutrophilia, elevated C-reactive protein and liver cytolysis. The blood and urine cultures, as well as the serological hepatitis B and C, toxoplasmosis, Epstein Barr virus, Rubella, Herpes virus, and cytomegalovirus were negative. The chest X-ray established the diagnosis of pneumonia. The fever persisted for approximately 2 weeks after admission. On the 2nd week of admission, the patient began to experience gait difficulties complaining of pain in the right hip and ankle. The cardiology and pneumology consults revealed no pathological findings. The evolution was favorable after the initiation of Levofloxacin and MP infection was detected as we suspected. Moreover, the ultrasound of the hip revealed a mild joint effusion, while the ankle joint appeared to be normal at ultrasound. Thus, we established the diagnosis of hip and ankle arthritis based on the clinical and ultrasound findings.
INTERVENTIONS: Levofloxacin by vein was continued for 5 days, replaced afterwards with clarithromycin orally for 2 weeks. OUTCOMES: The gait difficulties persisted for approximately 5 months from the initial diagnosis, and improved once the titer of immunoglobulin M anti-MP antibodies lowered considerably. After more than 8 months, the patient was completely asymptomatic and the immunoglobulin M anti-MP was close to the normal range.
CONCLUSION: The awareness of MP-induced arthritis in children represents the cornerstone in preventing diagnostic delays and initiating the proper treatment.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33466220      PMCID: PMC7808456          DOI: 10.1097/MD.0000000000024316

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  25 in total

Review 1.  The protean manifestations of Mycoplasma pneumoniae infection in adults.

Authors:  H W Murray; H Masur; L B Senterfit; R B Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

Review 2.  Mycoplasma pneumoniae Infections in Childhood.

Authors:  T Prescott Atkinson; Ken B Waites
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

3.  Mycoplasma pneumoniae infection and arthritis in man.

Authors:  L A Hernandez; G E Urquhart; W C Dick
Journal:  Br Med J       Date:  1977-07-02

4.  Mycoplasma pneumoniae infection and neurological complications.

Authors:  G E Urquhart
Journal:  Br Med J       Date:  1979-12-08

Review 5.  Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection.

Authors:  Mitsuo Narita
Journal:  Pediatr Neurol       Date:  2009-09       Impact factor: 3.372

6.  The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection.

Authors:  N J Ali; M Sillis; B E Andrews; P F Jenkins; B D Harrison
Journal:  Q J Med       Date:  1986-03

Review 7.  Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis.

Authors:  Mitsuo Narita
Journal:  Front Microbiol       Date:  2016-01-28       Impact factor: 5.640

8.  Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015.

Authors:  Maimuna Carrim; Nicole Wolter; Alvaro J Benitez; Stefano Tempia; Mignon du Plessis; Sibongile Walaza; Fahima Moosa; Maureen H Diaz; Bernard J Wolff; Florette K Treurnicht; Orienka Hellferscee; Halima Dawood; Ebrahim Variava; Cheryl Cohen; Jonas M Winchell; Anne von Gottberg
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

9.  Early Inflammatory Status Related to Pediatric Obesity.

Authors:  Cristina Oana Mărginean; Lorena Elena Meliţ; Dana Valentina Ghiga; Maria Oana Mărginean
Journal:  Front Pediatr       Date:  2019-06-18       Impact factor: 3.418

10.  Microorganisms Associated With Pneumonia in Children <5 Years of Age in Developing and Emerging Countries: The GABRIEL Pneumonia Multicenter, Prospective, Case-Control Study.

Authors:  Thomas Bénet; Valentina Sánchez Picot; Mélina Messaoudi; Monidarin Chou; Tekchheng Eap; Jianwei Wang; Kunling Shen; Jean-William Pape; Vanessa Rouzier; Shally Awasthi; Nitin Pandey; Ashish Bavdekar; Sonali Sanghavi; Annick Robinson; Mala Rakoto-Andrianarivelo; Maryam Sylla; Souleymane Diallo; Pagbajabyn Nymadawa; Nymadawaagiin Naranbat; Graciela Russomando; Wilma Basualdo; Florence Komurian-Pradel; Hubert Endtz; Philippe Vanhems; Gláucia Paranhos-Baccalà
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

View more
  3 in total

Review 1.  Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

Authors:  Ali Dawood; Samah Attia Algharib; Gang Zhao; Tingting Zhu; Mingpu Qi; Kong Delai; Zhiyu Hao; Marawan A Marawan; Ihsanullah Shirani; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

2.  Increased Total Serum Immunoglobulin E Is Likely to Cause Complications of Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Lili Zhou; Yuan Li; Zhufei Xu; Xuyun Peng; Xiaoyan Gong; Lin Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-24       Impact factor: 5.293

3.  Mycoplasma pneumoniae Seroprevalence and Total IgE Levels in Patients with Juvenile Idiopathic Arthritis.

Authors:  Dimitri Poddighe; Diyora Abdukhakimova; Kuanysh Dossybayeva; Zaure Mukusheva; Maykesh Assylbekova; Marzhan Rakhimzhanova; Aigul Ibrayeva; Gaukhar Mukash; Yernas Tuleutayev
Journal:  J Immunol Res       Date:  2021-10-06       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.